echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > US$570 million!

    US$570 million!

    • Last Update: 2021-05-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    GBI learned that, recently, Beihai Kangcheng Pharmaceutical Co.


    At the same time, Beihai Kangcheng also obtained the exclusive right to authorize LB-001 in the Greater China region (including Mainland China, Taiwan, Hong Kong and Macau).


    According to the terms of the agreement, LogicBio can obtain a global exclusive authorization prepayment of US$10 million, a maximum of US$564 million in clinical development and commercial milestone payments, and a maximum double-digit royalties based on net sales.


    LogicBio Therapeutics is a clinical-stage gene therapy company that develops gene delivery and editing platform technologies.


    LogicBio's leading sAAVy capsid development platform is designed to support the development of therapies for the treatment of multiple indications and tissue diseases.






    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.